Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal InfectionChristopher Lucasti, Liviu Vasile, Dorel Sandesc, et al.British Journal of Clinical Pharmacology|February 8, 2016
Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluidJ G Coen van Hasselt, Matthew L Rizk, Mallika Lala, et al.British Journal of Clinical Pharmacology|December 20, 2019
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatinPratik Bhagunde, Francheska Colon-Gonzalez, Yang Liu, et al.Plos One|November 12, 2024
Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 studyGraham Cohen, Bernardo Rapoport, Sze W Chan, et al.Journal for Immunotherapy of Cancer|August 10, 2019
Immunogenicity of pembrolizumab in patients with advanced tumorsMarianne J H van Vugt, Julie A Stone, Rik H J M M De Greef, et al.Pageof 2